Félix Lobo
(Felix Lobo)

Personal Details

First Name:	Felix
Middle Name:
Last Name:	Lobo
Suffix:
RePEc Short-ID:	plo333
	http://www.felixlobo.com/
	Departamento de Economía Universidad Carlos III de Madrid C/Madrid 126 GETAFE 28093 MADRID, Spain
	+34 916249581

Affiliation

Departamento de Economía
Universidad Carlos III de Madrid

Madrid, Spain
http://www.eco.uc3m.es/
RePEc:edi:deuc3es (more details at EDIRC)

Citations

Many of the citations below have been collected in an experimental project, CitEc, where a more detailed citation analysis can be found. These are citations from works listed in RePEc that could be analyzed mechanically. So far, only a minority of all works could be analyzed. See under "Corrections" how you can help improve the citation analysis.

Working papers

1. Oliva Moreno, Juan & Lobo, Félix & Molina, Begoña & Monereo, Susana, 2003. "Direct healthcare costs of diabetes mellitus patients in Spain," UC3M Working papers. Economics we036827, Universidad Carlos III de Madrid. Departamento de Economía.

   Cited by:

   1. Ebere Akobundu & Jing Ju & Lisa Blatt & C. Mullins, 2006. "Cost-of-Illness Studies," PharmacoEconomics, Springer, vol. 24(9), pages 869-890, September.
   2. Arran Shearer & Adrian Bagust & F. Ampudia-Blasco & Belén Martínez-Lage Álvarez & Isabel Pérez Escolano & Gonzalo París, 2006. "Lifetime Health Consequences and Cost-effectiveness of Rosiglitazone in Combination with Metformin for the Treatment of Type 2 Diabetes in Spain," PharmacoEconomics, Springer, vol. 24(1), pages 49-59, November.
   3. Travis Minor, 2011. "The effect of diabetes on female labor force decisions: new evidence from the National Health Interview Survey," Health Economics, John Wiley & Sons, Ltd., vol. 20(12), pages 1468-1486, December.
   4. Mehdi Javanbakht & Hamid R Baradaran & Atefeh Mashayekhi & Ali Akbar Haghdoost & Mohammad E Khamseh & Erfan Kharazmi & Aboozar Sadeghi, 2011. "Cost-of-Illness Analysis of Type 2 Diabetes Mellitus in Iran," PLOS ONE, Public Library of Science, vol. 6(10), pages 1-7, October.
   5. David Nathanson & Ugne Sabale & Jan W. Eriksson & Thomas Nyström & Anna Norhammar & Urban Olsson & Johan Bodegård, 2018. "Healthcare Cost Development in a Type 2 Diabetes Patient Population on Glucose-Lowering Drug Treatment: A Nationwide Observational Study 2006–2014," PharmacoEconomics - Open, Springer, vol. 2(4), pages 393-402, December.
   6. Tatiana Dilla & Amparo Valladares & Claudia Nicolay & Javier Salvador & Jesús Reviriego & María Costi, 2012. "Healthcare Costs Associated with Change in Body Mass Index in Patients with Type 2 Diabetes Mellitus in Spain," Applied Health Economics and Health Policy, Springer, vol. 10(6), pages 417-430, November.
   7. Juan Oliva-Moreno & Julio López-Bastida & Rubén Osuna-Guerrero & Angel Montejo-González & Beatriz Duque-González, 2006. "The costs of schizophrenia in Spain," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 7(3), pages 179-184, September.
   8. Till Seuring & Olga Archangelidi & Marc Suhrcke, 2015. "The Economic Costs of Type 2 Diabetes: A Global Systematic Review," PharmacoEconomics, Springer, vol. 33(8), pages 811-831, August.

2. Desmet, Klaus & García, Clara Eugenia & Kujal, Praveen & Lobo, Félix, 2003. "Implementing R and D policies : an analysis of Spain's pharmaceutical research program," UC3M Working papers. Economics we035923, Universidad Carlos III de Madrid. Departamento de Economía.

   Cited by:

   1. Beatriz Junquera & María Mitre, 2007. "Value of bibliometric analysis for research policy: A case study of Spanish research into innovation and technology management," Scientometrics, Springer;Akadémiai Kiadó, vol. 71(3), pages 443-454, June.

Articles

1. Roger Feldman & Félix Lobo, 2013. "Competition in prescription drug markets: the roles of trademarks, advertising, and generic names," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 14(4), pages 667-675, August.

   Cited by:

   1. María-Isabel Farfan-Portet & Sophie Gerkens & Isabelle Lepage-Nefkens & Irmgard Vinck & Frank Hulstaert, 2014. "Are biosimilars the next tool to guarantee cost-containment for pharmaceutical expenditures?," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 15(3), pages 223-228, April.

2. Juan Oliva & Félix Lobo & Julio López-Bastida & Néboa Zozaya & Rosa Romay, 2005. "Indirect costs of cervical and breast cancers in Spain," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 6(4), pages 309-313, December.

   Cited by:

   1. L. M. Peña-Longobardo & J. Oliva-Moreno & C. Fernández-Rodriguez, 2023. "The effect of hepatitis C—associated premature deaths on labour productivity losses in Spain: a ten-year analysis," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 24(8), pages 1271-1283, November.
   2. Antinyan, Armenak & Bertoni, Marco & Corazzini, Luca, 2021. "Cervical cancer screening invitations in low and middle income countries: Evidence from Armenia," Social Science & Medicine, Elsevier, vol. 273(C).
   3. Alison Pearce & Paul Hanly & Aileen Timmons & Paul Walsh & Ciaran O’Neill & Eleanor O’Sullivan & Rachael Gooberman-Hill & Audrey Thomas & Pamela Gallagher & Linda Sharp, 2015. "Productivity Losses Associated with Head and Neck Cancer Using the Human Capital and Friction Cost Approaches," Applied Health Economics and Health Policy, Springer, vol. 13(4), pages 359-367, August.
   4. Jesse Kigozi & Sue Jowett & Martyn Lewis & Pelham Barton & Joanna Coast, 2016. "Estimating productivity costs using the friction cost approach in practice: a systematic review," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 17(1), pages 31-44, January.
   5. Antinyan, A. & Bertoni, M. & Corazzini, L., 2020. "Cancer screening invitations in the developing world," Health, Econometrics and Data Group (HEDG) Working Papers 20/13, HEDG, c/o Department of Economics, University of York.
   6. Mark P. Connolly & Cole Tashjian & Nikolaos Kotsopoulos & Aomesh Bhatt & Maarten J. Postma, 2017. "A comparison of average wages with age-specific wages for assessing indirect productivity losses: analytic simplicity versus analytic precision," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 18(6), pages 697-701, July.
   7. Hassan Serrier & Hélène Sultan-Taieb & Danièle Luce & Sophie Béjean, 2013. "Estimating the social cost of respiratory cancer cases attributable to occupational exposures in France," Post-Print halshs-00922838, HAL.
      • Hassan Serrier & Hélène Sultan-Taieb & Danièle Luce & Sophie Bejean, 2014. "Estimating the social cost of respiratory cancer cases attributable to occupational exposures in France," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 15(6), pages 661-673, July.
   8. Elżbieta Antczak & Katarzyna M. Miszczyńska, 2021. "Causes of Sickness Absenteeism in Europe—Analysis from an Intercountry and Gender Perspective," IJERPH, MDPI, vol. 18(22), pages 1-22, November.
   9. Jamison Pike & Scott D. Grosse, 2018. "Friction Cost Estimates of Productivity Costs in Cost-of-Illness Studies in Comparison with Human Capital Estimates: A Review," Applied Health Economics and Health Policy, Springer, vol. 16(6), pages 765-778, December.
   10. Juan Oliva-Moreno & Marta Trapero-Bertran & Luz Maria Peña-Longobardo & Raúl del Pozo-Rubio, 2017. "The Valuation of Informal Care in Cost-of-Illness Studies: A Systematic Review," PharmacoEconomics, Springer, vol. 35(3), pages 331-345, March.
   11. Juan Oliva-Moreno, 2012. "Loss of labour productivity caused by disease and health problems: what is the magnitude of its effect on Spain’s Economy?," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 13(5), pages 605-614, October.
   12. Błażej Łyszczarz & Karolina Sowa, 2022. "Production losses due to mortality associated with modifiable health risk factors in Poland," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 23(1), pages 33-45, February.
   13. Juan Oliva-Moreno & Julio López-Bastida & Angel Montejo-González & Rubén Osuna-Guerrero & Beatriz Duque-González, 2009. "The socioeconomic costs of mental illness in Spain," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 10(4), pages 361-369, October.
   14. Mennini, Francesco Saverio & Gitto, Lara, 2022. "Approaches to Estimating Indirect Costs in Healthcare: Motivations for Choice," MPRA Paper 112129, University Library of Munich, Germany.
   15. Christin Mellner & Micael Dahlen & Otto Simonsson, 2022. "Association between Lifetime Classic Psychedelic Use and Sick Leave in a Population-Based Sample," IJERPH, MDPI, vol. 19(18), pages 1-9, September.

3. Desmet, Klaus & Kujal, Praveen & Lobo, Felix, 2004. "Implementing R&D policies: an analysis of Spain's pharmaceutical research program," Research Policy, Elsevier, vol. 33(10), pages 1493-1507, December.

   Cited by:

   1. Beatriz Junquera & María Mitre, 2007. "Value of bibliometric analysis for research policy: A case study of Spanish research into innovation and technology management," Scientometrics, Springer;Akadémiai Kiadó, vol. 71(3), pages 443-454, June.

4. Roger Feldman & Felix Lobo, 1997. "Global Budgets and Excess Demand for Hospital Care," Health Economics, John Wiley & Sons, Ltd., vol. 6(2), pages 187-196, March.

   Cited by:

   1. Margit Malmmose & Karoline Mortensen & Claus Holm, 2018. "Global budgets in Maryland: early evidence on revenues, expenses, and margins in regulated and unregulated services," International Journal of Health Economics and Management, Springer, vol. 18(4), pages 395-408, December.
   2. N. Kalant, 1998. "Choice of hospital: comments on ‘global budgets and excess demand for hospital care’," Health Economics, John Wiley & Sons, Ltd., vol. 7(6), pages 557-559, September.
   3. Jon Magnussen & Lee Rivers Mobley, 1999. "The Impact of Market Environment on Excess Capacity and the Cost of an Empty Hospital Bed," International Journal of the Economics of Business, Taylor & Francis Journals, vol. 6(3), pages 383-398.
   4. Kjeld Møller Pedersen & Terkel Christiansen & Mickael Bech, 2005. "The Danish health care system: evolution ‐ not revolution ‐ in a decentralized system," Health Economics, John Wiley & Sons, Ltd., vol. 14(S1), pages 41-57, September.
   5. Ma, Ching-to Albert, 2004. "Public rationing and private cost incentives," Journal of Public Economics, Elsevier, vol. 88(1-2), pages 333-352, January.
   6. Chia-Hsuan Wu & Ching-Cheng Chang & Po-Chi Chen & Ken-Nan Kuo, 2013. "Efficiency and productivity change in Taiwan’s hospitals: a non-radial quality-adjusted measurement," Central European Journal of Operations Research, Springer;Slovak Society for Operations Research;Hungarian Operational Research Society;Czech Society for Operations Research;Österr. Gesellschaft für Operations Research (ÖGOR);Slovenian Society Informatika - Section for Operational Research;Croatian Operational Research Society, vol. 21(2), pages 431-453, March.
   7. Hung-pin Lai & Meng-Chi Tang, 2018. "Hospital efficiency under global budgeting: evidence from Taiwan," Empirical Economics, Springer, vol. 55(3), pages 937-963, November.
   8. Sergi Jimenez & Natalia Jorgensen & José María Labeaga, 2008. "Immigration and the Demand for Health in Spain," Working Papers 2008-38, FEDEA.
   9. Maria J. Perez-Villadóniga & Ana Rodriguez-Alvarez & David Roibas, 2022. "The contribution of resident physicians to hospital productivity," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 23(2), pages 301-312, March.
   10. A. Spithoven, 2009. "Why U.S. health care expenditure and ranking on health care indicators are so different from Canada’s," International Journal of Health Economics and Management, Springer, vol. 9(1), pages 1-24, March.

Chapters

1. F. Lobo & M. Caba-as Sáenz & R. González Pérez, 2005. "Review of economic studies of the pharmaceutical industry published over the last 20 years by Spanish economists," Chapters, in: Jaume Puig-Junoy (ed.), The Public Financing of Pharmaceuticals, chapter 11, Edward Elgar Publishing.

   Cited by:

   1. Corsetti, Giancarlo & Müller, Gernot & Meier, André, 2009. "Fiscal Stimulus with spending reversals," CEPR Discussion Papers 7302, C.E.P.R. Discussion Papers.
      • Gernot Müller & Giancarlo Corsetti & Mr. Andre Meier, 2009. "Fiscal Stimulus with Spending Reversals," IMF Working Papers 2009/106, International Monetary Fund.
      • Giancarlo Corsetti & André Meier & Gernot J. Müller, 2012. "Fiscal Stimulus with Spending Reversals," The Review of Economics and Statistics, MIT Press, vol. 94(4), pages 878-895, November.
   2. Bloise, Gaetano & Polemarchakis, Herakles, 2015. "An argument for positive nominal interest," The Warwick Economics Research Paper Series (TWERPS) 1104, University of Warwick, Department of Economics.
      • Bloise, Gaetano & Polemarchakis, Herakles, 2015. "An argument for positive nominal interest," CRETA Online Discussion Paper Series 14, Centre for Research in Economic Theory and its Applications CRETA.
      • Gaetano Bloise & Herakles Polemarchakis, 2017. "An Argument for Positive Nominal Interest," Studies in Economic Theory, in: Kazuo Nishimura & Alain Venditti & Nicholas C. Yannelis (ed.), Sunspots and Non-Linear Dynamics, chapter 0, pages 363-385, Springer.
      • Bloise, Gaetano & Polemarchakis, Herakles, 2015. "An argument for positive nominal interest," Economic Research Papers 269721, University of Warwick - Department of Economics.
   3. Peiris, M.Udara & Polemarchakis, Herakles, 2015. "Quantitative Easing in an Open Economy : Prices, Exchange Rates and Risk Premia," The Warwick Economics Research Paper Series (TWERPS) 1094, University of Warwick, Department of Economics.
      • Udara Peiris, M & Polemarchakis, Herakles, 2015. "Quantitative Easing in an Open Economy: Prices, Exchange Rates and Risk Premia," Economic Research Papers 270000, University of Warwick - Department of Economics.
      • Peiris, M.Udara & Polemarchakis, Herakles, 2015. "Quantitative Easing in an Open Economy : Prices, Exchange Rates and Risk Premia," CRETA Online Discussion Paper Series 09, Centre for Research in Economic Theory and its Applications CRETA.
   4. Giancarlo Corsetti & Keith Kuester & Gernot J. Müller, 2011. "Floats, Pegs and the Transmission of Fiscal Policy," Journal Economía Chilena (The Chilean Economy), Central Bank of Chile, vol. 14(2), pages 5-38, August.
      • Giancarlo Corsetti & Keith Kuester & Gernot J. Müller, 2013. "Floats, Pegs and the Transmission of Fiscal Policy," Central Banking, Analysis, and Economic Policies Book Series, in: Luis Felipe Céspedes & Jordi Galí (ed.),Fiscal Policy and Macroeconomic Performance, edition 1, volume 17, chapter 7, pages 235-281, Central Bank of Chile.
      • Corsetti, Giancarlo & Müller, Gernot & Kuester, Keith, 2011. "Floats, pegs and the transmission of fiscal policy," CEPR Discussion Papers 8180, C.E.P.R. Discussion Papers.
      • Giancarlo Corsetti & Keith Kuester & Gernot J. Müller, 2011. "Floats, Pegs and the Transmission of Fiscal Policy," Working Papers Central Bank of Chile 608, Central Bank of Chile.
      • Giancarlo Corsetti & Keith Kuester & Gernot J. Müller, 2011. "Floats, pegs and the transmission of fiscal policy," Working Papers 11-9, Federal Reserve Bank of Philadelphia.
   5. McMahon, Michael & Peiris, Udara & Polemarchakis, Herakles, 2015. "Perils of Quantitative Easing," Economic Research Papers 270005, University of Warwick - Department of Economics.
      • McMahon, Michael & Peiris, Udara & Polemarchakis, Herakles, 2015. "Perils of quantitative easing," The Warwick Economics Research Paper Series (TWERPS) 1089, University of Warwick, Department of Economics.
      • McMahon, Michael & Peiris, Udara & Polemarchakis, Herakles, 2015. "Perils of quantitative easing," CRETA Online Discussion Paper Series 04, Centre for Research in Economic Theory and its Applications CRETA.
   6. Giancarlo Corsetti & André Meier & Gernot J. Müller, 2010. "Cross-Border Spillovers from Fiscal Stimulus," International Journal of Central Banking, International Journal of Central Banking, vol. 6(1), pages 5-37, March.
      • Corsetti, Giancarlo & Müller, Gernot & Meier, André, 2009. "Cross-border spillovers from fiscal stimulus," CEPR Discussion Papers 7535, C.E.P.R. Discussion Papers.
   7. Born, Benjamin & Juessen, Falko & Müller, Gernot J., 2013. "Exchange rate regimes and fiscal multipliers," Journal of Economic Dynamics and Control, Elsevier, vol. 37(2), pages 446-465.
      • Müller, Gernot & Born, Benjamin & Juessen, Falko, 2012. "Exchange rate regimes and fiscal multipliers," CEPR Discussion Papers 8986, C.E.P.R. Discussion Papers.

More information

Research fields, statistics, top rankings, if available.

Statistics

Access and download statistics for all items

Co-authorship network on CollEc

NEP Fields

NEP is an announcement service for new working papers, with a weekly report in each of many fields. This author has had 2 papers announced in NEP. These are the fields, ordered by number of announcements, along with their dates. If the author is listed in the directory of specialists for this field, a link is also provided.

1. NEP-COM: Industrial Competition (1) 2003-11-09
2. NEP-IFN: International Finance (1) 2004-03-07
3. NEP-INO: Innovation (1) 2003-11-09
4. NEP-TID: Technology and Industrial Dynamics (1) 2003-11-09

Corrections

All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. For general information on how to correct material on RePEc, see these instructions.

To update listings or check citations waiting for approval, Felix Lobo
(Felix Lobo) should log into the RePEc Author Service.

To make corrections to the bibliographic information of a particular item, find the technical contact on the abstract page of that item. There, details are also given on how to add or correct references and citations.

To link different versions of the same work, where versions have a different title, use this form. Note that if the versions have a very similar title and are in the author's profile, the links will usually be created automatically.

Please note that most corrections can take a couple of weeks to filter through the various RePEc services.